While most people who contract COVID-19 will be able to manage symptoms and recover at home, there are some who have a more severe course of the disease and need to be hospitalized. Physicians and scientists have learned a lot about COVID-19 in the first nine months of the pandemic, and that new knowledge is improving treatments for patients hospitalized with COVID-19.

On the Mayo Clinic Q&A podcast, Dr. Raymund Razonable, a Mayo Clinic infectious diseases specialist, discusses management of hospitalized patients with COVID-19, including therapeutics available to treat COVID-19.

When patients are diagnosed with COVID-19, they are required to self-isolate until the infection is cleared. Some patients will be at risk for complications, and may need comprehensive support at home. Providing that support is the goal of Mayo Clinic's remote patient monitoring team.

On the Mayo Clinic Q&A podcast, Dr. Ryan T. Hurt, a Mayo Clinic general internal medicine specialist, explains how remote monitoring benefits patients. Dr. Hurt helped form the team that manages positive COVID-19 test results at Mayo Clinic in Rochester and the Mayo Clinic Health System.

It has been a remarkable year of discoveries and medical advances at Mayo Clinic's Center for Individualized Medicine. Some innovations include personalized treatments for cancer and rare diseases, and the development of lifesaving artificial intelligence algorithms. All of the center’s efforts are driven by advanced genetic analysis and aimed at providing patients with answers, treatment options and optimism. On the Mayo Clinic Q&A podcast, Dr. John Kalantari discusses artificial general intelligence. Dr. Kalantari is an associate consultant in the Department of Surgery, and a faculty member in the Mayo Clinic Center for Individualized Medicine Microbiome Program. He has a joint appointment in the department of Health Sciences Research. His research focuses on artificial general intelligence and the development of AI algorithms for predictive analytics, clinical decision-making and causal inference for preventive medicine.

It has been a remarkable year of discoveries and medical advances at Mayo Clinic's Center for Individualized Medicine. Some innovations include personalized treatments for cancer and rare diseases, and the development of lifesaving artificial intelligence algorithms. All of the center’s efforts are driven by advanced genetic analysis and aimed at providing patients with answers, treatment options and optimism. On the Mayo Clinic Q&A podcast, Dr. Marina Walther-Antonio discusses the microbiome and gynecologic cancers. Dr. Walther-Antonio is assistant professor in the Department of Surgery and in the Mayo Clinic Center for Individualized Medicine Microbiome Program. She has a joint appointment in the department of Obstetrics and Gynecology. Her research focuses on the role of the human microbiome in women's health.

It has been a remarkable year of discoveries and medical advances at Mayo Clinic's Center for Individualized Medicine. Some innovations include personalized treatments for cancer and rare diseases, and the development of lifesaving artificial intelligence algorithms. All of the center’s efforts are driven by advanced genetic analysis and aimed at providing patients with answers, treatment options and optimism. On the Mayo Clinic Q&A podcast, Dr. Jewel Samadder discusses precision oncology. Dr. Samadder associate program director for the Gastroenterology and Hepatology Fellowship Program and program leader for clinical genomics in the Center for Individualized Medicine in Arizona. He also is an associate medical director in the Department of Development. Dr. Samadder’s research focuses on colorectal cancer and inherited predisposition to cancer.

A new study from Mayo Clinic, published in the American Journal of Transplantation, found that patients with polycystic kidney disease (PKD) can have dual surgery safely. This means patients with large polycystic kidneys in need of a kidney transplant can have their diseased kidneys safely removed at the same time as their transplant surgery, instead of having two separate procedures.

On the Mayo Clinic Q&A podcast, Dr. Mikel Prieto, a Mayo Clinic transplant surgeon and senior author of the study, explains the results of the study and the benefits of dual surgery for PKD.

During the COVID-19 pandemic, women have reportedly skipped or delayed their regular breast cancer screenings. This may lead to a surge in breast cancer diagnoses in the months ahead. That's according to a study in JAMA.

October is Breast Cancer Awareness Month and Dr. Katie Hunt, a Mayo Clinic radiologist, says it's the perfect time to make sure women are up to date on their breast cancer screenings.

In this Mayo Clinic Q&A podcast, Dr. Hunt discusses a variety of recommendations for screening and encourages women not to miss the window of opportunity to catch breast cancer early.

With the COVID-19 pandemic entering a tenth month, experts says adherence to public health measures appears to be waning in some parts of the country. "COVID fatigue," meaning failing to comply with masking, hand hygiene and physical distancing guidelines, has fueled a resurgence in COVID-19 cases in more than half of the U.S. states.

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the rising number of COVID-19 cases and how vaccine experts in science and industry are working together in unprecedented ways.
Research disclosures for Dr. Gregory Poland.

Transplants are identified as nonelective surgeries, and transplant patients have faced urgent medical needs during the COVID-19 pandemic.

"Our practice, like many others across the country, did slow down in March and April of this year," says Dr. Patrick Dean, a Mayo Clinic transplant surgeon. "Patients and providers were concerned ― appropriately so ― about what would happen with this pandemic and whether it would be safe to have a transplant or for that matter any health care that wasn't absolutely emergent."

In this "Mayo Clinic Q&A" podcast, Dr. Dean talks about taking care of transplant patients; overcoming surgery challenges during the pandemic; the increased risks transplant patients have of developing SARS-CoV-2, the virus that causes COVID-19, because of compromised immune systems; and the important need for COVID-19 testing.

The COVID-19 pandemic has accelerated the use of digital health care, with telemedicine playing a big role in treating patients during the pandemic. But telemedicine appointments are just the tip of the iceberg when it comes to changing the way health care will be delivered in the future.

Mayo Clinic Platform is a collection of initiatives focused on transforming health care by using technology, big data and artificial intelligence to make connections. On the Mayo Clinic Q&A podcast, Dr. John Halamka, president of Mayo Clinic Platform, explains how the platform initiatives are meeting patient needs and creating new care delivery possibilities.